Edboard disclosure
S Baylin is a member of the Epigenomics Editorial Board. They were not involved in any editorial decisions related to the publication of this article, and all author details were blinded to the article’s peer reviewers as per the journal’s double-blind peer review policy.
Interview disclosure
The opinions expressed in this interview are those of S Baylin and do not necessarily reflect the views of Future Medicine Ltd/Future Science Ltd/Newlands Press Ltd.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.